$BKUH
Bakhu Holdings, Corp.

2022 Q4 Form 10-K Financial Statement

#000109690622002650 Filed on November 07, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2022
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.989M $5.311M $18.04M
YoY Change -5.32% 84.6% 164.47%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $33.42K $38.26K $76.52K
YoY Change
% of Gross Profit
Operating Expenses $5.022M $5.311M $18.04M
YoY Change -4.69% 84.6% 164.47%
Operating Profit -$5.022M -$18.04M
YoY Change -4.69% 164.47%
Interest Expense $46.66K -$43.28K $136.9K
YoY Change -268.89% 65.38% -302.41%
% of Operating Profit
Other Income/Expense, Net $4.528M $15.38M
YoY Change -2.38% 214.36%
Pretax Income -$5.135M -$5.354M -$20.91M
YoY Change -3.06% 84.42% 203.55%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$5.135M -$5.354M -$20.91M
YoY Change -3.06% 84.42% 203.55%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$17.04K -$17.77K -$69.46K
COMMON SHARES
Basic Shares Outstanding 301.3M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022 Q3 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.11K $12.45K $12.45K
YoY Change -98.26% -73.47% -73.47%
Cash & Equivalents $20.11K $12.45K $12.45K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $20.11K $12.45K $12.45K
YoY Change -98.26% -73.47% -73.47%
LONG-TERM ASSETS
Property, Plant & Equipment $568.1K $688.6K $688.6K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $568.1K $688.6K $688.7K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $20.11K $12.45K $12.45K
Total Long-Term Assets $568.1K $688.6K $688.7K
Total Assets $588.2K $701.1K $701.1K
YoY Change -49.24% 1393.92% 1393.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.589M $1.266M $1.266M
YoY Change 105.12% 153.41% 153.41%
Accrued Expenses $265.6K $218.9K $218.9K
YoY Change 142.3% 167.01% 167.01%
Deferred Revenue
YoY Change
Short-Term Debt $6.593M $6.374M $6.374M
YoY Change 208.45% 230.11% 230.11%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.447M $7.859M $7.859M
YoY Change 179.56% 212.8% 212.8%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $8.447M $7.859M $7.859M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $8.447M $7.859M $7.859M
YoY Change 179.56% 212.8% 212.8%
SHAREHOLDERS EQUITY
Retained Earnings -$48.66M -$43.53M
YoY Change 92.48%
Common Stock $301.3K $301.3K
YoY Change 0.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$7.859M -$7.158M -$7.158M
YoY Change
Total Liabilities & Shareholders Equity $588.2K $701.1K $701.1K
YoY Change -49.24% 1393.92% 1393.93%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2022
OPERATING ACTIVITIES
Net Income -$5.135M -$5.354M -$20.91M
YoY Change -3.06% 84.42% 203.55%
Depreciation, Depletion And Amortization $33.42K $38.26K $76.52K
YoY Change
Cash From Operating Activities -$221.2K -$338.6K -$2.583M
YoY Change -59.81% -12.17% 43.98%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $10.13K $0.00 $0.00
YoY Change
Cash From Investing Activities $10.13K $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $218.8K 335.4K $2.549M
YoY Change -86.84% -22.2% 39.94%
NET CHANGE
Cash From Operating Activities -$221.2K -338.6K -$2.583M
Cash From Investing Activities $10.13K 0.000 $0.00
Cash From Financing Activities $218.8K 335.4K $2.549M
Net Change In Cash $7.662K -3.250K -$34.48K
YoY Change -99.31% -107.14% -226.85%
FREE CASH FLOW
Cash From Operating Activities -$221.2K -$338.6K -$2.583M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-07-31
CY2022 dei Entity File Number
EntityFileNumber
000-55862
CY2022 dei Entity Registrant Name
EntityRegistrantName
Bakhu Holdings, Corp.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-0510649
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
One World Trade Center
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 130
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Long Beach
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90831
CY2022 dei City Area Code
CityAreaCode
858
CY2022 dei Local Phone Number
LocalPhoneNumber
682-2528
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 dei Entity Public Float
EntityPublicFloat
334307745 usd
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
301282983 shares
CY2022 dei Auditor Name
AuditorName
BF Borgers CPA PC
CY2022 dei Auditor Firm
AuditorFirmId
5041
CY2022 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12451 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46929 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
12451 usd
CY2021Q3 us-gaap Assets Current
AssetsCurrent
46929 usd
CY2022Q3 us-gaap Property Plant And Equipment Owned Accumulated Depreciation
PropertyPlantAndEquipmentOwnedAccumulatedDepreciation
76516 usd
CY2021Q3 us-gaap Property Plant And Equipment Owned Accumulated Depreciation
PropertyPlantAndEquipmentOwnedAccumulatedDepreciation
0 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
688644 usd
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 usd
CY2022Q3 us-gaap Other Assets
OtherAssets
688644 usd
CY2021Q3 us-gaap Other Assets
OtherAssets
0 usd
CY2022Q3 us-gaap Assets
Assets
701095 usd
CY2021Q3 us-gaap Assets
Assets
46929 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1265968 usd
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
499580 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
218919 usd
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
81987 usd
CY2022Q3 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
6373731 usd
CY2021Q3 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
1930783 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
7858618 usd
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2512350 usd
CY2022Q3 us-gaap Liabilities
Liabilities
7858618 usd
CY2021Q3 us-gaap Liabilities
Liabilities
2512350 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
4 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
4 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
4 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
4 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
301282983 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
301282983 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
300697980 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
300697980 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
301283 usd
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
300698 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
36070822 usd
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
19848569 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-43529628 usd
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-22614688 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-7157523 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-2465421 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
701095 usd
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
46929 usd
CY2022 us-gaap Revenues
Revenues
0 usd
CY2021 us-gaap Revenues
Revenues
0 usd
CY2022 us-gaap Other Expenses
OtherExpenses
15379799 usd
CY2021 us-gaap Other Expenses
OtherExpenses
4892478 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
900492 usd
CY2021 us-gaap Professional Fees
ProfessionalFees
535361 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1762877 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1394524 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
18043168 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
6822363 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-18043168 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-6822363 usd
CY2022 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
2734839 usd
CY2021 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
CY2022 us-gaap Interest Expense
InterestExpense
136933 usd
CY2021 us-gaap Interest Expense
InterestExpense
67647 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2871772 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-67647 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-20914940 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-6890010 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-20914940 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-6890010 usd
CY2022 fil Basic Net Loss Per Share
BasicNetLossPerShare
-0.07
CY2021 fil Basic Net Loss Per Share
BasicNetLossPerShare
-0.02
CY2022 fil Weighted Average Number Of Shares Outstanding
WeightedAverageNumberOfSharesOutstanding
301113657 shares
CY2021 fil Weighted Average Number Of Shares Outstanding
WeightedAverageNumberOfSharesOutstanding
300256860 shares
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-419664 usd
CY2021 fil Stock Issued For Cash
StockIssuedForCash
-265000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
4579252 usd
CY2021 fil Stock Issued For The Exercise Of Stock Options
StockIssuedForTheExerciseOfStockOptions
0 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-6890010 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-2465421 usd
CY2022 fil Stock Issued For Cash
StockIssuedForCash
-1606004 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
14616834 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-20914940 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-7157523 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-20914940 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-6890010 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-14616834 usd
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-4579253 usd
CY2022 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
2734839 usd
CY2021 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
CY2022 us-gaap Depreciation
Depreciation
76517 usd
CY2021 us-gaap Depreciation
Depreciation
0 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
766388 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
449176 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
136932 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
67251 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2583430 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1794330 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2022 fil Stock Issued For Cash
StockIssuedForCash
-1606004 usd
CY2021 fil Stock Issued For Cash
StockIssuedForCash
-265000 usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
116046 usd
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
163713 usd
CY2022 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1058994 usd
CY2021 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1720218 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2548952 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1821505 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-34478 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
27175 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46929 usd
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19754 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12451 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46929 usd
CY2022 us-gaap Interest Paid
InterestPaid
0 usd
CY2021 us-gaap Interest Paid
InterestPaid
0 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022 fil Issuance Of Notes Payable For Fixed Assets
IssuanceOfNotesPayableForFixedAssets
765161 usd
CY2021 fil Issuance Of Notes Payable For Fixed Assets
IssuanceOfNotesPayableForFixedAssets
0 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 usd
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
495 usd
CY2022 us-gaap Nature Of Operations
NatureOfOperations
<p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"><b>NOTE 1 - ORGANIZATION AND BUSINESS OPERATIONS</b></p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify">Bakhu Holdings, Corp. (formerly Planet Resources, Corp.) (“the Company”) was incorporated under the laws of the State of Nevada, U.S., on April 24, 2008. In May 2009, the Company began to look for other types of business to pursue that would benefit the stockholders. To pursue businesses outside the mining industry the name of the Company was changed with the approval of the directors and stockholders to Bakhu Holdings, Corp. on May 4, 2009.</p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify">The Company has not generated any revenue to date and consequently its operations are subject to all risks inherent in the establishment of a new business enterprise. For the period from inception, April 24, 2008 through July 31, 2022 the Company has accumulated losses of $43,529,628.</p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify">On August 9, 2019, the Company formed Cell Science CBD International, Inc., a California corporation as a wholly owned subsidiary to commercialize use of the licensed technology to produce and manufacture cannabis and their byproducts that have measurable tetrahydrocannabinol (THC) concentration potency less than 3% on a dry weight basis. This subsidiary had no active operations as of July 31, 2022.  When used herein, the “Company” includes this consolidated subsidiary.</p>
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2008-04-24
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-43529628 usd
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-43529628 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"><kbd style="position:absolute;font:10pt Times New Roman;margin-left:0pt">d)</kbd><kbd style="margin-left:36pt"/><span style="border-bottom:1px solid #000000">Use of Estimates and Assumptions</span> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"> </p>
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
1200000 shares
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q2 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
7000000 shares
CY2022 us-gaap Fiscal Period
FiscalPeriod
<p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"><kbd style="position:absolute;font:10pt Times New Roman;margin-left:0pt">k) </kbd><kbd style="margin-left:36pt"/><span style="border-bottom:1px solid #000000">Fiscal Periods</span> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify">The Company’s fiscal year end is July 31.</p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"> </p>
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
765160 usd
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
0 usd
CY2022Q3 us-gaap Property Plant And Equipment Owned Accumulated Depreciation
PropertyPlantAndEquipmentOwnedAccumulatedDepreciation
76516 usd
CY2021Q3 us-gaap Property Plant And Equipment Owned Accumulated Depreciation
PropertyPlantAndEquipmentOwnedAccumulatedDepreciation
0 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
688644 usd
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 usd
CY2019Q2 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
10199 usd
CY2022 fil Stock Issued For Cash Shares
StockIssuedForCashShares
88334 shares
CY2021 fil Stock Issued For Cash
StockIssuedForCash
-265000 usd
CY2020Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
20000000 shares
CY2022 fil Share Based Compensation Arrangement By Share Based Payment Award Options Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised
-800000 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
5.10
CY2022 fil Shares Canceled In Payment Of The Aggregate Exercise Price
SharesCanceledInPaymentOfTheAggregateExercisePrice
304354 shares
CY2022 fil License Fee
LicenseFee
250000 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
765160 usd
CY2022 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
2734839 usd

Files In Submission

Name View Source Status
0001096906-22-002650-index-headers.html Edgar Link pending
0001096906-22-002650-index.html Edgar Link pending
0001096906-22-002650.txt Edgar Link pending
0001096906-22-002650-xbrl.zip Edgar Link pending
bakh10k_1.jpg Edgar Link pending
bakh_ex31z1.htm Edgar Link pending
bakh_ex31z2.htm Edgar Link pending
bakh_ex32.htm Edgar Link pending
bkhu-20220731.htm Edgar Link pending
bkhu-20220731.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
bkhu-20220731_pre.xml Edgar Link unprocessable
bkhu-20220731_cal.xml Edgar Link unprocessable
bkhu-20220731_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bkhu-20220731_def.xml Edgar Link unprocessable
bkhu-20220731_htm.xml Edgar Link completed